PlugBioIn SIGNED
Plug and play enzymes for an accelerated uptake of Biocatalysis in the Pharmaceutical Industry
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0PlugBioIn project word cloud
Explore the words cloud of the PlugBioIn project. It provides you a very rough idea of what is the project "PlugBioIn" about.
Project "PlugBioIn" data sheet
The following table provides information about the project.
| Coordinator |
C-LECTA GMBH
Organization address contact info |
| Coordinator Country | Germany [DE] |
| Project website | http://www.c-lecta.com/products-services/products/customized-enzyme-c-lections/c-lecta-plug-play-biocats/ |
| Total cost | 681˙125 € |
| EC max contribution | 476˙787 € (70%) |
| Programme |
1. H2020-EU.2.1.4. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) |
| Code Call | H2020-SMEINST-2-2014 |
| Funding Scheme | SME-2 |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-01-01 to 2017-06-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | C-LECTA GMBH | DE (LEIPZIG) | coordinator | 476˙787.00 |
Map
Project objective
At present there is a mismatch between the extensive interest of the pharmaceutical industry to utilize enzyme technology in their production processes and the number of such processes commercially implemented. To overcome this mismatch c-LEcta aims at offering a smart platform of Plug & Play enzymes for the three most relevant enzyme classes (alcohol dehydrogenase, transaminases, and nitrilase). The platform will address the needs of the pharma industry for performing essential biocatalytic reactions suitable for the production of million fold applied chiral active pharmaceutical ingredients (APIs) like Atorvastatin, Rosuvastatin and Duloxetine. The API market is valued at $101.08 billion in 2010. The unique selling proposition of this platform is to comprise ~100 high quality enzymes per class, which are pre-qualified for a wide range of important structural patterns, applicable for synthesis processes and easily scalable. Therefore, the business opportunity is to take advantage of the great potential of biocatalysis since the platform allows matching timelines and cost requirements. Up to now such service was not available without contract signing and extensive development timelines and costs. The development cost may be reduced up to ~80% by using the new platform technology compared to the conventional work flow. In manufacturing, the total production cost of a product will be typically reduced by > 30%. The platform will be promoted to a medium volume market with high growth rates. c-LEcta will address the global market, which is going to be widened step-by-step. Subject matter of Phase 2 c-LEcta is to refine the design of the enzyme platform, to scale up the enzyme production, synthesis process development and pilot-scale application in order to demonstrate and to assure rapid availability of enzymes in pharma development and for subsequent commercialization.
Deliverables
| Website for online ordering | Websites, patent fillings, videos etc. | 2019-05-30 12:54:33 |
| Webinar on enzyme platform | Websites, patent fillings, videos etc. | 2019-05-30 12:54:26 |
Take a look to the deliverables list in detail: detailed list of PlugBioIn deliverables.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2017 |
Michael Burns, Carlos A. Martinez, Brian Vanderplas, Richard Wisdom, Shu Yu, Robert A. Singer A Chemoenzymatic Route to Chiral Intermediates Used in the Multikilogram Synthesis of a Gamma Secretase Inhibitor published pages: 871-877, ISSN: 1083-6160, DOI: 10.1021/acs.oprd.7b00096 |
Organic Process Research & Development 21/6 | 2019-07-08 |
| 2017 |
Tim Börner, Sebastian Rämisch, Sebastian Bartsch, Andreas Vogel, Patrick Adlercreutz, Carl Grey Three in One: Temperature, Solvent and Catalytic Stability by Engineering the Cofactor-Binding Element of Amine Transaminase published pages: 1482-1486, ISSN: 1439-4227, DOI: 10.1002/cbic.201700236 |
ChemBioChem 18/15 | 2019-07-08 |
| 2017 |
Konrad B. Otte, Elena Maurer, Marko Kirtz, Daniela Grabs, Eric Althoff, Sebastian Bartsch, Andreas Vogel, Bettina M. Nestl, Bernhard Hauer Synthesis of Sebacic Acid Using a De Novo Designed Retro-Aldolase as a Key Catalyst published pages: 1378-1382, ISSN: 1867-3880, DOI: 10.1002/cctc.201601551 |
ChemCatChem 9/8 | 2019-07-08 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLUGBIOIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PLUGBIOIN" are provided by the European Opendata Portal: CORDIS opendata.